Drug Profile
Celiprolol - Acer Therapeutics
Alternative Names: ACER-002; EDSIVO; VASEBRALatest Information Update: 23 Nov 2023
Price :
$50
*
At a glance
- Originator Acer Therapeutics
- Class Antihypertensives; Heart failure therapies; Ischaemic heart disorder therapies; Phenylurea compounds; Propanolamines; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Angina pectoris; Hypertension
- Preregistration Ehlers-Danlos syndrome